MEDAG was shown to be involved in glucose and lipid metabolism in adipocytes in a previous study5, and multiple studies have suggested that the AKT/AMPK/mTOR pathway may contribute to tumor development, energy metabolism, and protein synthesis in cancer; we finally identified the above pathway10. The gene discussed is MEDAG; the disease is cancer.